BIOECLIPSE THERAPEUTICS, INC.

Profile

Company Names

BIOECLIPSE THERAPEUTICS, INC.

Addresses

329 OYSTER POINT BLVD., 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

408.809.1030

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$10,126,014.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-06-07 
$10,126,014.00 
$11,768,260.00 
$1,642,246.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELONA 
 
BAUM 
DIRECTOR
ABILITECH MEDICAL, INC.   |  BIOECLIPSE THERAPEUTICS, INC.   |  AEGLE THERAPEUTICS CORP   |  ORIG3N, INC.   |  ENDOGENA THERAPEUTICS, INC.
BENJAMIN 
 
CARTER 
EXECUTIVE OFFICER
SOUTHPOINT OFFSHORE FUND, LTD.   |  BIOECLIPSE THERAPEUTICS, INC.   |  TCWA ESPERANZA GOM, LLC   |  TCWA TURNS, LLC   |  TCC PLATINUM CREDIT, LLC   |  TCC PERPETUAL, LLC   |  TURTLE CREEK CREDIT FUND I, LP   |  TCC BM POWER, LLC   |  TCC ACADIA, LLC
PAMELA 
 
CONTAG 
EXECUTIVE OFFICER, DIRECTOR
MARRONE BIO INNOVATIONS INC   |  BIOECLIPSE THERAPEUTICS, INC.
MARK 
 
FROHLICH 
DIRECTOR
JUNO THERAPEUTICS, INC.   |  BIOECLIPSE THERAPEUTICS, INC.   |  INDAPTA THERAPEUTICS INC.
BIAO 
 
HE 
DIRECTOR
BIOECLIPSE THERAPEUTICS, INC.   |  BLUE LAKE BIOTECHNOLOGY, INC.   |  CARDEA BIO, INC.   |  APPLAUD MEDICAL, INC.   |  AVOTRES INC.   |  AVVIO MEDICAL, INC.
PAMELA 
 
REILLY CONTAG 
EXECUTIVE OFFICER, DIRECTOR
BIOECLIPSE THERAPEUTICS, INC.
GREGORY 
 
SCHIFFMAN 
DIRECTOR
BIOECLIPSE THERAPEUTICS, INC.   |  ABSCI CORP
CATHERINE 
 
SOHN 
DIRECTOR
NEURALSTEM, INC.   |  RUBIUS THERAPEUTICS, INC.   |  LANDEC CORP \CA\   |  BIOECLIPSE THERAPEUTICS, INC.
STEPHEN 
 
THAU 
EXECUTIVE OFFICER
BAXANO, INC.   |  DNANEXUS, INC.   |  BIOECLIPSE THERAPEUTICS, INC.   |  SIGHT SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-07 
2019-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
VENTURE.CO BROKERAGE SERVICES LLC
173924